This article has been updated from a previous version to include comments made during Bruker's earning call.

NEW YORK (GenomeWeb) – Bruker reported after the close of the market Tuesday that its second quarter revenues were up 12 percent year over year.

For the three months ended June 30, Billerica, Massachusetts-based Bruker reported revenues of $414.9 million, compared to $371.7 million in Q2 2016.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.